Race-Based Stress and Cognitive Training for MCI
Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment
1 other identifier
interventional
9
1 country
1
Brief Summary
This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of stress on cognitive functioning; that integrates components from the Race Based Stress and Empowerment (RBSE) group for an increased focus on race-based stress and discrimination for racial minority older adults (i.e., RBSEF-CCT-MCI). In a pilot open trial, 75-150 participants will receive group-based intervention for 8 weeks, with 8-10 participants per group. Following the pilot study, the investigators will complete a randomized controlled trial (RCT) (Phase 2) to compare the efficacy of the RBSEF-CCT-MCI with the ME-CCT. In the RCT, 75-150 participants will be randomized into either 1) The active control group, who will complete the original, ME-CCT training program, or 2) The experimental group, who will complete the newly developed RBSE-CCT-MCI. Both research groups will complete the interventions for 8 weeks, with 8-10 participants per group. Hypothesis: Participation in this newly developed/updated intervention (i.e., RBSEF-CCT-MCI) will result in improvements in both (a) subjective and (b) objective cognitive functioning, and (c) self-reported mental health symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2024
CompletedFirst Posted
Study publicly available on registry
March 26, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 15, 2028
July 24, 2025
April 1, 2025
2.5 years
February 9, 2024
July 21, 2025
Conditions
Outcome Measures
Primary Outcomes (11)
Verbal learning and memory
Assessed by the California Verbal Learning Test- Second Edition (CVLT-II)
up to eight weeks
Basic auditory attention and working memory
Assessed by the Digit Span subtest of the Wechsler Adult Intelligence Scale (WAIS-IV)
up to eight weeks
Psychomotor processing speed
Assessed by the Coding and Symbol search subtests of the WAIS-IV
up to eight weeks
Psychomotor processing speed; executive functioning
As assessed by the Stroop Test
up to eight weeks
Self-report of prospective and retrospective memory
The Prospective and Retrospective Memory Questionnaire (PRMQ). The PRMQ developed to provide a self-report measure of prospective and retrospective memory slips in everyday life. It consists of sixteen items, eight asking about prospective memory failures, and eight concerning retrospective failures.
up to eight weeks
Self-report of cognitive concerns
Neuro-QOL (neuro-quality of life); applied cognition: general concerns \& executive functioning (EF) subscales
up to eight weeks
The Patient Health Questionnaire-9
(i.e., PHQ-9; assessing self-report symptoms of depression)
up to eight weeks
Self-report symptoms of anxiety
As assessed by the Generalized Anxiety Disorder-7 questionnaire (i.e., GAD-7)
up to eight weeks
Self-reported daily functioning
As assessed by The World Health Organization Disability Assessment Schedule 2.0 (i.e., WHODAS 2.0)
up to eight weeks
The Racial Microaggressions Scale
Assessing the occurrence and distress elicited by racial indignities, slights, mistreatment, or offenses that people of color may face on a recurrent or consistent basis.
up to eight weeks
The Trauma Symptoms of Discrimination Scale
Self-report measure assessing the traumatizing impact of discrimination broadly by measuring anxiety-related symptoms of trauma due to discriminatory experiences
up to eight weeks
Study Arms (2)
Experimental: RBSEF-CCT-MCI
EXPERIMENTALParticipants will complete the newly developed RBSE-CCT-MCI training program.
Control Group: ME-CCT
OTHERParticipants will complete the original, ME-CCT training program.
Interventions
RBSEF-CCT-MCI differs from ME-CCT in that this intervention integrates psychoeducation and strategies for processing and coping with race/ethnicity-related stressors, as part of the larger conversation in ME-CCT regarding stress, and how stress interferes with attention, learning, and subsequently one's subjective sense of memory.
ME-CCT focuses on: 1. Cognitive training, psychotherapeutic, and lifestyle techniques. 2. Incorporates CCT techniques designed to help patients manage problems with memory, attention, and executive functions (i.e., organization, planning, decision-making, and problem-solving). 3. Includes mindfulness-based stress reduction practice which has been shown to improve cognitive and neuropsychiatric function in various populations.
Eligibility Criteria
You may qualify if:
- The study will be conducted in-person, so they must be able to travel to Rosalind Franklin University.
- The study will initially be limited to participants who self-identify as Black/African American, or who self-identify with other racial/ethnic groups in addition to self-identifying as Black/African-American; however, may be expanded to include participants that identify as Hispanic/Latine.
You may not qualify if:
- Participants are ineligible to participate in this study if they are not at least 65 years of age and are not experiencing at least mild cognitive impairment or self-reported cognitive difficulties.
- Participants will also be excluded if they have a diagnosis of dementia (i.e., major neurocognitive disorder), intellectual disability, mild head injury (i.e., concussion) within the last six months, and/or a history of moderate to severe traumatic brain injury.
- Diagnosis of dementia may be from self-report or other medical records, or for participants to fail screening cognitive assessments (i.e., the RBANS) that would suggest they may be at the level of dementia (i.e., major neurocognitive disorder) as ultimately determined by study PI with objective scores less then 2 standard deviations below the mean on the RBANS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rosalind Franklin University of Medicine and Science
Chicago, Illinois, 60064, United States
Related Publications (6)
Huckans M, Hutson L, Twamley E, Jak A, Kaye J, Storzbach D. Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions. Neuropsychol Rev. 2013 Mar;23(1):63-80. doi: 10.1007/s11065-013-9230-9. Epub 2013 Mar 8.
PMID: 23471631BACKGROUNDNayak US. Design participation by the thousand elders. Stud Health Technol Inform. 1998;48:423-7. No abstract available.
PMID: 10186562BACKGROUNDKremer A, Focaccia G, Ferreyra R, Kraly A, Sniechowski T. [The epidemiology of cancer in the Province of Neuquen, Argentina]. Medicina (B Aires). 1987;47(5):471-6. No abstract available. Spanish.
PMID: 3504986BACKGROUNDFritsch J, Wolf P. [Cog-rail extension corset in the surgical management of scoliosis]. Beitr Orthop Traumatol. 1973 Feb;20(2):124-7. No abstract available. German.
PMID: 4700211BACKGROUNDSpruill TM, Butler MJ, Thomas SJ, Tajeu GS, Kalinowski J, Castaneda SF, Langford AT, Abdalla M, Blackshear C, Allison M, Ogedegbe G, Sims M, Shimbo D. Association Between High Perceived Stress Over Time and Incident Hypertension in Black Adults: Findings From the Jackson Heart Study. J Am Heart Assoc. 2019 Nov 5;8(21):e012139. doi: 10.1161/JAHA.119.012139. Epub 2019 Oct 16.
PMID: 31615321BACKGROUNDInoue S. Uptake of 3-H-DL-leucine and 3-H-uridine by the caudal neurosecretory system of the loach (Misgurnus anguillicaudatus) maintained in vitro. Endocrinol Jpn. 1968 Dec;15(4):505-7. doi: 10.1507/endocrj1954.15.505. No abstract available.
PMID: 5756074BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachael L Ellison, PhD
Rosalind Franklin University of Medicine and Science
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
February 9, 2024
First Posted
March 26, 2024
Study Start
March 1, 2025
Primary Completion (Estimated)
September 15, 2027
Study Completion (Estimated)
March 15, 2028
Last Updated
July 24, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share